26
Views
6
CrossRef citations to date
0
Altmetric
Oncology

Inverse correlation between Skp2 and p27Kip1 in normal endometrium and endometrial carcinoma

, , , , , , & show all
Pages 220-229 | Received 25 Mar 2009, Accepted 20 Jul 2009, Published online: 12 Feb 2010
 

Abstract

Cyclin-dependent-kinase (cdk) inhibitor, p27Kip1 (p27), has been shown to participate in progestin-induced growth suppression of normal endometrial glands. To analyse the molecular mechanisms regulating p27 protein, we examined immunohistochemical expression of the SCFSkp2 (Skp1-Cullin-F-box protein) complex factors, i.e. Skp1, Cul1 and Skp2, and compared them with that of p27, steroid receptors and Ki-67. In normal endometrial glands, the expression of Skp2 was observed in the proliferative phase, whereas that of p27 was observed in the secretory phase. Cultured normal endometrial glandular cells showed that progesterone induced the down-regulation of Skp2 along with up-regulation of p27. In endometrial carcinomas, the inverse topological correlation between Skp2 and p27 was evident in 39/66 (59%) cases, and the expression of Skp2 showed a strong correlation with Ki-67. These findings suggest that the expression of SCFSkp2 complex changes during the menstrual cycle in normal endometrium and the SCFSkp2 ubiquitin-proteasome pathway may also work in endometrial carcinomas.

Acknowledgements

This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Science and Culture (No. 06454468 and No. 07807154), Japan.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.